FATE Insider Transactions
444 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
FATE insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| TAHL CINDY | See Remarks | 2026-08-04 | Sale | 38,800 | $2.4589 |
| Valamehr Bahram | President and CEO | 2026-08-04 | Sale | 43,947 | $2.4598 |
| TAHL CINDY | See Remarks | 2026-05-20 | Sale | 25,590.0 | $1.88 |
| Valamehr Bahram | President and CEO | 2026-05-20 | Sale | 28,946.0 | $1.88 |
| TAHL CINDY | See Remarks | 2026-01-09 | Sale | 10,589.0 | $1.06 |
| Valamehr Bahram | President and CEO | 2026-01-09 | Sale | 5,190.0 | $1.07 |
| TAHL CINDY | See Remarks | 2025-08-04 | Sale | 9,037.0 | $1.06 |
| Valamehr Bahram | President and CEO | 2025-08-04 | Sale | 14,466.0 | $1.06 |
| Bressi Jerome Charles | See Remarks | 2025-01-10 | Sale | 5,980.0 | $1.55 |
| TAHL CINDY | See Remarks | 2025-01-10 | Sale | 5,654.0 | $1.55 |
| Valamehr Bahram | President and CEO | 2025-01-10 | Sale | 8,705.0 | $1.54 |
| Redmile Group, LLC | Director,TenPercentOwner | 2024-12-20 | Purchase | 397,964.0 | $1.68 |
| Green Jeremy | Director,TenPercentOwner | 2024-12-20 | Purchase | 397,964.0 | $1.68 |
| Redmile Group, LLC | Director,TenPercentOwner | 2024-12-20 | Sale | 341,633.0 | $1.68 |
| Green Jeremy | Director,TenPercentOwner | 2024-12-20 | Sale | 341,633.0 | $1.68 |
| Xu Yuan | Director | 2024-08-06 | Sale | 633.0 | $4.23 |
| Dulac Edward J III | Chief Financial Officer | 2024-03-04 | Sale | 2,447.0 | $7.77 |
| Dulac Edward J III | Chief Financial Officer | 2024-01-29 | Sale | 1,849.0 | $5.0 |
| TAHL CINDY | General Counsel and Secretary | 2024-01-09 | Sale | 10,874.0 | $4.37 |
| Valamehr Bahram | Chief R&D Officer | 2024-01-09 | Sale | 11,271.0 | $4.38 |
| Wolchko J Scott | President and CEO | 2024-01-09 | Sale | 14,391.0 | $4.37 |
| Dulac Edward J III | Chief Financial Officer | 2024-01-09 | Sale | 7,028.0 | $4.37 |
| Dulac Edward J III | Chief Financial Officer | 2024-01-02 | Sale | 5,182.0 | $3.66 |
| Redmile Group, LLC | Director,TenPercentOwner | 2023-12-26 | Purchase | 44,630.0 | $3.72 |
| Green Jeremy | Director,TenPercentOwner | 2023-12-26 | Purchase | 44,630.0 | $3.72 |
| Dulac Edward J III | Chief Financial Officer | 2023-12-18 | Sale | 1,585.0 | $3.5 |
| TAHL CINDY | General Counsel and Secretary | 2023-11-09 | Sale | 24,363.0 | $2.4 |
| Dulac Edward J III | Chief Financial Officer | 2023-08-18 | Sale | 4,718.0 | $2.8 |
| Xu Yuan | Director | 2023-08-04 | Sale | 632.0 | $3.71 |
| Powl Brian T. | Chief Commercial Officer | 2023-07-05 | Sale | 3,854.0 | $4.87 |
| Dulac Edward J III | Chief Financial Officer | 2023-07-05 | Sale | 5,182.0 | $4.83 |
| Xu Yuan | Director | 2023-06-14 | Sale | 3,460.0 | $5.58 |
| Redmile Group, LLC | Director,TenPercentOwner | 2023-04-21 | Purchase | 256,639.0 | $6.18 |
| Green Jeremy | Director,TenPercentOwner | 2023-04-21 | Purchase | 256,639.0 | $6.18 |
| Redmile Group, LLC | Director,TenPercentOwner | 2023-04-20 | Purchase | 20,000.0 | $5.99 |
| Green Jeremy | Director,TenPercentOwner | 2023-04-20 | Purchase | 20,000.0 | $5.99 |
| Chu Yu-Waye | Chief Medical Officer | 2023-04-18 | Sale | 2,317.0 | $6.58 |
| Chu Yu-Waye | Chief Medical Officer | 2023-04-18 | Sale | 215.0 | $6.52 |
| Redmile Group, LLC | Director,TenPercentOwner | 2023-04-14 | Purchase | 25,700.0 | $6.0 |
| Green Jeremy | Director,TenPercentOwner | 2023-04-14 | Purchase | 25,700.0 | $6.0 |
| Redmile Group, LLC | Director,TenPercentOwner | 2023-04-14 | Sale | 302,339.0 | $5.84 |
| Green Jeremy | Director,TenPercentOwner | 2023-04-14 | Sale | 302,339.0 | $5.84 |
| MENDLEIN JOHN | Director | 2023-01-13 | Purchase | 36,631.0 | $5.43 |
| MENDLEIN JOHN | Director | 2023-01-11 | Purchase | 88,048.0 | $5.67 |
| Wolchko J Scott | President and CEO | 2023-01-10 | Sale | 45,907.0 | $5.24 |
| Valamehr Bahram | Chief R&D Officer | 2023-01-10 | Sale | 10,917.0 | $5.24 |
| TAHL CINDY | General Counsel and Secretary | 2023-01-10 | Sale | 11,553.0 | $5.24 |
| Plavsic Mark | Chief Technical Officer | 2023-01-10 | Sale | 3,418.0 | $5.24 |
| Dulac Edward J III | Chief Financial Officer | 2023-01-10 | Sale | 7,331.0 | $5.24 |
| Chu Yu-Waye | Chief Medical Officer | 2023-01-10 | Sale | 7,825.0 | $5.24 |
| Dulac Edward J III | Chief Financial Officer | 2022-08-18 | Sale | 432.0 | $30.41 |
| Dulac Edward J III | Chief Financial Officer | 2022-08-18 | Sale | 4,703.0 | $29.75 |
| Wolchko J Scott | President and CEO | 2022-07-22 | Sale | 620.0 | $33.28 |
| Wolchko J Scott | President and CEO | 2022-07-22 | Sale | 2,703.0 | $32.61 |
| Wolchko J Scott | President and CEO | 2022-07-22 | Sale | 2,923.0 | $31.33 |
| Wolchko J Scott | President and CEO | 2022-07-21 | Sale | 19,171.0 | $33.07 |
| Wolchko J Scott | President and CEO | 2022-07-21 | Sale | 10,829.0 | $32.54 |
| Valamehr Bahram | Chief R&D Officer | 2022-07-07 | Sale | 17,158.0 | $30.23 |
| Valamehr Bahram | Chief R&D Officer | 2022-07-06 | Sale | 7,842.0 | $30.07 |
| Plavsic Mark | Chief Technical Officer | 2022-07-05 | Sale | 3,719.0 | $24.61 |
| Agarwal Shefali | Director | 2022-06-07 | Sale | 841.0 | $21.89 |
| Agarwal Shefali | Director | 2022-06-03 | Sale | 0.0 | $0.0 |
| MENDLEIN JOHN | Director | 2022-06-03 | Sale | 1,364.0 | $22.79 |
| Jooss Karin | Director | 2022-06-03 | Sale | 1,483.0 | $22.82 |
| HERSHBERG ROBERT | Director | 2022-06-03 | Sale | 672.0 | $22.75 |
| COUGHLIN TIMOTHY | Director | 2022-06-03 | Sale | 1,439.0 | $22.81 |
| Agarwal Shefali | Director | 2022-06-03 | Sale | 807.0 | $22.8 |
| TAHL CINDY | General Counsel and Secretary | 2022-06-01 | Sale | 25,000.0 | $22.96 |
| Wolchko J Scott | President and CEO | 2022-04-22 | Sale | 838.0 | $35.15 |
| Wolchko J Scott | President and CEO | 2022-04-22 | Sale | 9,162.0 | $34.54 |
| Wolchko J Scott | President and CEO | 2022-04-21 | Sale | 1,003.0 | $37.9 |
| Wolchko J Scott | President and CEO | 2022-04-21 | Sale | 2,220.0 | $36.7 |
| Wolchko J Scott | President and CEO | 2022-04-21 | Sale | 4,062.0 | $35.73 |
| Wolchko J Scott | President and CEO | 2022-04-21 | Sale | 22,715.0 | $34.57 |
| Chu Yu-Waye | Chief Medical Officer | 2022-04-19 | Sale | 4,062.0 | $35.37 |
| TAHL CINDY | General Counsel and Secretary | 2022-04-01 | Sale | 25,000.0 | $38.85 |
| Valamehr Bahram | Chief R&D Officer | 2022-03-14 | Sale | 100.0 | $34.04 |
| Valamehr Bahram | Chief R&D Officer | 2022-03-14 | Sale | 2,960.0 | $33.3 |
| Valamehr Bahram | Chief R&D Officer | 2022-03-14 | Sale | 2,195.0 | $32.49 |
| Valamehr Bahram | Chief R&D Officer | 2022-03-14 | Sale | 3,067.0 | $31.66 |
| Valamehr Bahram | Chief R&D Officer | 2022-03-14 | Sale | 16,678.0 | $30.36 |
| MENDLEIN JOHN | Director | 2022-03-10 | Sale | 12,069.0 | $35.48 |
| MENDLEIN JOHN | Director | 2022-03-10 | Sale | 19,493.0 | $34.73 |
| Wolchko J Scott | President and CEO | 2022-01-21 | Sale | 10,000.0 | $38.02 |
| Wolchko J Scott | President and CEO | 2022-01-20 | Sale | 30,000.0 | $40.21 |
| Wolchko J Scott | President and CEO | 2022-01-11 | Sale | 4,519.0 | $49.07 |
| Wolchko J Scott | President and CEO | 2022-01-11 | Sale | 10,047.0 | $48.5 |
| TAHL CINDY | General Counsel and Secretary | 2022-01-11 | Sale | 536.0 | $49.15 |
| TAHL CINDY | General Counsel and Secretary | 2022-01-11 | Sale | 4,883.0 | $48.46 |
| Valamehr Bahram | Chief R&D Officer | 2022-01-11 | Sale | 418.0 | $49.12 |
| Valamehr Bahram | Chief R&D Officer | 2022-01-11 | Sale | 4,152.0 | $48.44 |
| Dulac Edward J III | Chief Financial Officer | 2022-01-11 | Sale | 390.0 | $49.16 |
| Dulac Edward J III | Chief Financial Officer | 2022-01-11 | Sale | 1,380.0 | $48.25 |
| Chu Yu-Waye | Senior VP Clinical Development | 2022-01-11 | Sale | 418.0 | $49.1 |
| Chu Yu-Waye | Senior VP Clinical Development | 2022-01-11 | Sale | 3,547.0 | $48.44 |
| Wolchko J Scott | President and CEO | 2022-01-10 | Sale | 101.0 | $47.72 |
| Wolchko J Scott | President and CEO | 2022-01-10 | Sale | 20,894.0 | $47.17 |
| Wolchko J Scott | President and CEO | 2022-01-10 | Sale | 13,161.0 | $46.36 |
| TAHL CINDY | General Counsel and Secretary | 2022-01-10 | Sale | 643.0 | $47.15 |
| TAHL CINDY | General Counsel and Secretary | 2022-01-10 | Sale | 7,095.0 | $46.37 |